Response to the letter: Hyperprogression in advanced melanoma is not restricted to immunotherapy.

Eur J Cancer

Université Paris Cite, Dermato-Oncology AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cite, INSERM U976, F-75010 Paris, France. Electronic address:

Published: March 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2024.113562DOI Listing

Publication Analysis

Top Keywords

response letter
4
letter hyperprogression
4
hyperprogression advanced
4
advanced melanoma
4
melanoma restricted
4
restricted immunotherapy
4
response
1
hyperprogression
1
advanced
1
melanoma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!